主页 > 医学文档 >
【社会人文】新计划将为最穷国家购买200万美元
New plan will buy US$200 million in vaccines for poorest countries
The Associated PressPublished: November 29, 2006
BERLIN: An international organization working to increasing vaccination in the developing world said Wednesday it would devote US$200 million to help poor countries protect children against pneumococcus and rotavirus — two leading causes of preventable childhood death.
Officials of the Geneva-based GAVI Alliance said at a news conference in Berlin that they hoped to overcome barriers that often lead to years-long delays before new vaccines introduced in the wealthier parts of the world are put into use in the world's poorest countries.
Pneumococcus is a major cause of pneumonia, meningitis and sepsis, or blood poisoning, while rotavirus causes diarrhea and vomiting. Together, they kill an estimated 1.5 million children each year.
"This new investment in child health care will bring new, live-saving vaccines to the developing world faster than ever before," said Orin Levine, executive director of GAVI's PneumoADIP program aimed at pneumococcus and located at the Johns Hopkins Bloomberg School of Public Heath in the United States.
Today in Europe
EU may suspend key areas of talks with Turkey
NATO to offer Serbia partnership
Putin's RSVP to Chirac: 'Non, merci'He predicted the effort could save some 4 million children through 2025.
The money comes from GAVI's partners, which include national governments, the World Bank and the World Heath Organization, UNICEF, and non-governmental organizations.
The new vaccines will be introduced beginning next year — against rotavirus in 13 countries in Latin America and Eastern Europe and against pneumococcal vaccine in up to 10 eligible countries in Africa and South Asia.
One reason vaccine availability lags is cost, as new vaccines are generally more expensive when they are first introduced; other factors are inadequate infrastructure and lack of planning.
The oral vaccines against rotavirus are RotaTeq, made by Merck, and Rotarix, created by AVANT and licensed to GlaxoSmithKline. The pneumococcus vaccine is Prevnar, manufactured by Lederle Laboratories Division and marketed by Wyeth Pharmaceuticals. 本人已认领该文编译，48小时后若未提交译文，请其他战友自由认领。 New plan will buy US$200 million in vaccines for poorest countries
The Associated Press Published: November 29, 2006
新计划将为最穷国家购买200万美元的疫苗
美联社报道：2006年11月29日
BERLIN: An international organization working to increasing vaccination in the developing world said Wednesday it would devote US$200 million to help poor countries protect children against pneumococcus and rotavirus — two leading causes of preventable childhood death.
柏林：一个致力于促进发展中国家疫苗接种的国际性组织宣布在本周三将捐赠200万美元以帮助贫穷国家的儿童免受肺炎球菌和轮状病毒感染——两种主要的可预防的儿童死亡因素。
Officials of the Geneva-based GAVI Alliance said at a news conference in Berlin that they hoped to overcome barriers that often lead to years-long delays before new vaccines introduced in the wealthier parts of the world are put into use in the world's poorest countries.
在柏林举行的新闻发布会上，全球疫苗免与疫联盟（GAVI）在日内瓦总部的官员称，新研制的疫苗经常是富裕地区新已经推广数年之后才在世界上最贫穷的国家中应用，他们希望能排除导致这种情况的障碍。
Pneumococcus is a major cause of pneumonia, meningitis and sepsis, or blood poisoning, while rotavirus causes diarrhea and vomiting. Together, they kill an estimated 1.5 million children each year.
肺炎球菌是导致肺炎、脑脊膜炎和脓毒血症或败血症的主要病因，而轮状病毒可导致恶心与呕吐。这两种病原体估计每年总共可导致150万儿童死亡。
"This new investment in child health care will bring new, live-saving vaccines to the developing world faster than ever before," said Orin Levine, executive director of GAVI's PneumoADIP program aimed at pneumococcus and located at the Johns Hopkins Bloomberg School of Public Heath in the United States.
肺炎球菌疫苗加速开发与推广计划的执行董事Orin Levine说：“此项在儿童卫生保健方面的投资将以比以往更快的速度为发展中国家提供新的救助疫苗。” 该计划的总部设在美国约翰霍普金斯大学公共卫生学院，其目标是防治肺炎球菌感染。
He predicted the effort could save some 4 million children through 2025.
他预测该计划到2025年将挽救约400万儿童的生命。
The money comes from GAVI's partners, which include national governments, the World Bank and the World Heath Organization, UNICEF, and non-governmental organizations.
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-04-29 14:38
医学,生命科学网